Pfizer recalls one million birth control pills

By Kristin Stoller and Mindy Szkaradnik

One million packets of defective birth control were recalled Wednesday after a defect that could decrease the pills’ contraceptive efficiency was discovered.

Pfizer Inc., a pharmaceutical company, identified problems in 14 lots of Lo/Ovral-28 oral tablets and 14 lots of Norgestrel and Ethinyl Estradiol oral tablets. All were since recalled, according to a press release on Pfizer’s website.

Pfizer spokesman Chris Loder said though one million packets were recalled, only about 28 packets were affected.

“If we identify even one packet, our strong commitment to quality compels us to recall entire lots,” Loder said.

Some of the pills may have inexact counts of active ingredients may be out of sequence, according to the press release.

Though the defects will not cause any immediate health risks, they could increase the risk of pregnancy by leaving women with inadequate contraception, according to the press release.

The expiration dates on the packages range from July 31, 2013 to March 31, 2014, according to the press release.

The issue was identified as a result of a customer complaint, Loder said in an email. An investigation was launched at the manufacturing plant to determine the root cause of the issue, he said.

Following a retail level recall in late December, the Food and Drug Administration completed its own assessment and determined that a patient-level recall was warranted. It requested that Pfizer issue a press release to broadly inform patients, which it did last night, Loder wrote in the email.

Pfizer is advising consumers who have been exposed to the defective pills to begin using a non-hormonal form of contraception immediately, Loder said. He said consumers should go to pfizer.com to see pictures and lot numbers of the product.

Anyone who is in possession of the recalled products is also advised to notify their physician and return the product to the pharmacy, according to the press release.

Penn State U. Health Services Director Dr. Margaret Spear said anyone who has questions about the recall should call Qualitest at 1-877-300-6153 between 8 a.m. and 5 p.m. Central Time.

The pharmaceutical company said it corrected the problem for their future products, according to the release.

“Pfizer has responded rapidly to ensure that its products continue to meet the company’s high quality standards. The safety of patients who take our medicines is our first priority,” the release states.

Read more here: http://www.collegian.psu.edu/archive/2012/02/02/birth_control_recalled_across_country.aspx
Copyright 2026 Daily Collegian